Analysis of St. Jude Medical’s Optim-insulated leads reveals low rates of mechanical failures, conductor fractures and all-cause abrasions by five years. “The bottom line of it all is that the results are very good,” the lead researcher told Cardiovascular Business.

When every minute counts, delaying treatment can have enormous repercussions. An analysis of U.S. data finds that while door-to-balloon times have improved, many patients may still not receive care within the recommended 120 minutes, due in part to transfers to STEMI care centers.

Patients awaiting heart transplants can continue on ventricular assist devices for longer periods now, thanks to smaller profile devices with improved functionality, the Boston Globe reports.

For patients who received no shocks from an implantable cardioverter-defibrillator (ICD) before the end of its battery life, it may be worth considering a new risk-benefit analysis.

Consider it one more reason to make that surgery a quick one. Researchers found that the longer a surgery goes, the more risk of venous thromboembolism (VTE) for the patient. 

Miniaturization and 3D modeling help to provide new technologies to meet the needs of pediatric patients with congenital heart defects.

One of medicine's most prominent experts in sudden cardiac arrest has received a new $2.36 million grant to study how to better predict the deadly heart condition that kills an estimated 300,000 Americans each year.

Tendyne Holdings, Inc. ("Tendyne"), a privately held clinical stage medical device company, announced today that the Tendyne Transcatheter Mitral Valve system has been successfully implanted in three patients.